{"id":398524,"date":"2020-12-11T19:03:08","date_gmt":"2020-12-12T00:03:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=398524"},"modified":"2020-12-11T19:03:08","modified_gmt":"2020-12-12T00:03:08","slug":"gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/","title":{"rendered":"GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">SAN DIEGO<\/span>, <span class=\"xn-chron\">Dec. 11, 2020<\/span> \/PRNewswire\/ &#8211;Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against GoodRx Holdings, Inc.\u00a0(&#8220;GoodRx&#8221; or the &#8220;Company&#8221;) (NASDAQ: GDRX) for potential violations of federal securities laws.<\/p>\n<p>On <span class=\"xn-chron\">September 23, 2020<\/span>, GoodRx sold about 34.6 million shares of stock in its initial public stock offering (the &#8220;IPO&#8221;) at <span class=\"xn-money\">$33.00<\/span> a share, raising approximately <span class=\"xn-money\">$1.1 billion<\/span> in new capital. Post-IPO, GoodRx stock traded at a high of <span class=\"xn-money\">$64.22<\/span>; on <span class=\"xn-chron\">December 10, 2020<\/span>, the stock closed at <span class=\"xn-money\">$38.92<\/span>.<\/p>\n<p>Specifically, <span class=\"xn-person\">Johnson Fistel&#8217;s<\/span> investigation seeks to determine whether the Company&#8217;s filings with the U.S. Securities and Exchange Commission in connection with its <span class=\"xn-chron\">September 2020<\/span> IPO contained untrue statements of material facts or omitted to state other facts necessary to make the statements made therein not misleading concerning the Company&#8217;s business, and operations.<\/p>\n<p>\n        <b>If you have information that could assist in this investigation, or if you are a GoodRx\u00a0shareholder and are interested in learning more about the investigation, please contact <span class=\"xn-person\">Jim Baker<\/span> (<u><a target=\"_blank\" href=\"mailto:jimb@johnsonfistel.com\" rel=\"nofollow noopener noreferrer\">jimb@johnsonfistel.com<\/a><\/u>) at 619-814-4471. If emailing, please include a phone number.<\/b>\n      <\/p>\n<p>Additionally, you can [<b><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3010456-1&amp;h=2242933120&amp;u=https%3A%2F%2Fwww.cognitoforms.com%2FJohnsonFistel%2FGoHealthInc&amp;a=Click+here+to+join+this+action\" rel=\"nofollow noopener noreferrer\">Click here to join this action<\/a><\/b>]. There is no cost or obligation to you.<\/p>\n<p>\n        <b>About <span class=\"xn-person\">Johnson Fistel<\/span>, LLP:<br \/><\/b><br \/>\n        <span class=\"xn-person\">Johnson Fistel<\/span>, LLP is a nationally recognized shareholder rights law firm with offices in <span class=\"xn-location\">California<\/span>, <span class=\"xn-location\">New York<\/span> and <span class=\"xn-location\">Georgia<\/span>. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3010456-1&amp;h=1882515534&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2878927-1%26h%3D4215658078%26u%3Dhttps%253A%252F%252Fwww.globenewswire.com%252FTracker%253Fdata%253Dc_2rAG0I6cJzdFVkn_hJHXFcD-DprZhrEZf7_GhIIKQlshBPHLEQriopLatQK1sUkUSgKxieEn5jbj3rmuVqsblYb_7cls2l_ShYO-KqFqJOJDaDG7IXiX0yZGtc3zjB_51VwQ4EO9MwXDDyL7BYXgsiEe8ARpnjUnkfqxva_evagJrxUwdh2I0nux1IVvVEOtm4Y5wvQHuorGVI5SfcuBiCZQj-xIEJt005kF-m__LgcRux8XmIXxJea5K_xsZX%26a%3Dhttp%253A%252F%252Fwww.johnsonfistel.com&amp;a=http%3A%2F%2Fwww.johnsonfistel.com\" rel=\"nofollow noopener noreferrer\">http:\/\/www.johnsonfistel.com<\/a>. Attorney advertising. Past results do not guarantee future outcomes.<\/p>\n<p>\n        <b>Contact:<br \/><\/b><br \/>\n        <span class=\"xn-person\">Johnson Fistel<\/span>, LLP<br \/><span class=\"xn-person\">Jim Baker<\/span>, 619-814-4471 <br \/><a target=\"_blank\" href=\"mailto:jimb@johnsonfistel.com\" rel=\"nofollow noopener noreferrer\">jimb@johnsonfistel.com<\/a><\/p>\n<p>[<b><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3010456-1&amp;h=2242933120&amp;u=https%3A%2F%2Fwww.cognitoforms.com%2FJohnsonFistel%2FGoHealthInc&amp;a=Click+here+to+join+this+action\" rel=\"nofollow noopener noreferrer\">Click here to join this action<\/a><\/b>]<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH21417&amp;sd=2020-12-11\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm-301191287.html\">http:\/\/www.prnewswire.com\/news-releases\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm-301191287.html<\/a><\/p>\n<p>SOURCE  <span class=\"xn-person\">Johnson Fistel<\/span>, LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PH21417&amp;Transmission_Id=202012111900PR_NEWS_USPR_____PH21417&amp;DateId=20201211\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SAN DIEGO, Dec. 11, 2020 \/PRNewswire\/ &#8211;Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against GoodRx Holdings, Inc.\u00a0(&#8220;GoodRx&#8221; or the &#8220;Company&#8221;) (NASDAQ: GDRX) for potential violations of federal securities laws. On September 23, 2020, GoodRx sold about 34.6 million shares of stock in its initial public stock offering (the &#8220;IPO&#8221;) at $33.00 a share, raising approximately $1.1 billion in new capital. Post-IPO, GoodRx stock traded at a high of $64.22; on December 10, 2020, the stock closed at $38.92. Specifically, Johnson Fistel&#8217;s investigation seeks to determine whether the Company&#8217;s filings with the U.S. Securities and Exchange Commission in connection with its September 2020 IPO contained untrue statements of material facts or omitted to state other &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-398524","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN DIEGO, Dec. 11, 2020 \/PRNewswire\/ &#8211;Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against GoodRx Holdings, Inc.\u00a0(&#8220;GoodRx&#8221; or the &#8220;Company&#8221;) (NASDAQ: GDRX) for potential violations of federal securities laws. On September 23, 2020, GoodRx sold about 34.6 million shares of stock in its initial public stock offering (the &#8220;IPO&#8221;) at $33.00 a share, raising approximately $1.1 billion in new capital. Post-IPO, GoodRx stock traded at a high of $64.22; on December 10, 2020, the stock closed at $38.92. Specifically, Johnson Fistel&#8217;s investigation seeks to determine whether the Company&#8217;s filings with the U.S. Securities and Exchange Commission in connection with its September 2020 IPO contained untrue statements of material facts or omitted to state other &hellip; Continue reading &quot;GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-12T00:03:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH21417&amp;sd=2020-12-11\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm\",\"datePublished\":\"2020-12-12T00:03:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\\\/\"},\"wordCount\":295,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH21417&amp;sd=2020-12-11\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\\\/\",\"name\":\"GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH21417&amp;sd=2020-12-11\",\"datePublished\":\"2020-12-12T00:03:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH21417&amp;sd=2020-12-11\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=PH21417&amp;sd=2020-12-11\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm - Market Newsdesk","og_description":"PR Newswire SAN DIEGO, Dec. 11, 2020 \/PRNewswire\/ &#8211;Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against GoodRx Holdings, Inc.\u00a0(&#8220;GoodRx&#8221; or the &#8220;Company&#8221;) (NASDAQ: GDRX) for potential violations of federal securities laws. On September 23, 2020, GoodRx sold about 34.6 million shares of stock in its initial public stock offering (the &#8220;IPO&#8221;) at $33.00 a share, raising approximately $1.1 billion in new capital. Post-IPO, GoodRx stock traded at a high of $64.22; on December 10, 2020, the stock closed at $38.92. Specifically, Johnson Fistel&#8217;s investigation seeks to determine whether the Company&#8217;s filings with the U.S. Securities and Exchange Commission in connection with its September 2020 IPO contained untrue statements of material facts or omitted to state other &hellip; Continue reading \"GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-12T00:03:08+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH21417&amp;sd=2020-12-11","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm","datePublished":"2020-12-12T00:03:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/"},"wordCount":295,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH21417&amp;sd=2020-12-11","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/","name":"GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH21417&amp;sd=2020-12-11","datePublished":"2020-12-12T00:03:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH21417&amp;sd=2020-12-11","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH21417&amp;sd=2020-12-11"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gdrx-alert-johnson-fistel-launches-investigation-into-goodrx-investors-suffering-losses-encouraged-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GDRX Alert: Johnson Fistel Launches Investigation into GoodRx; Investors Suffering Losses Encouraged to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/398524","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=398524"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/398524\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=398524"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=398524"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=398524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}